🇳🇱 Netherlands Country × Condition
obesity Clinical Trials in Netherlands
Active clinical trials for obesity with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 4, Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇳🇱 Netherlands
Active Trials in Netherlands (5)
NCT05651724
Recruiting
Global Research Initiative for Patients Screening on MASH
Enrollment
10,000 pts
Country
🇳🇱 Netherlands
Julius Clinical
View Trial → NCT06184633 Phase 4
Recruiting
DUTCH Weight Control in Atrial Fibrillation Study
Enrollment
280 pts
Country
🇳🇱 Netherlands
Rijnstate Hospital
View Trial → NCT06384313
Recruiting
Butyrate-enriched Triglyceride and Diabetes Prevention
Enrollment
48 pts
Country
🇳🇱 Netherlands
Maastricht University Medical Cente...
View Trial → NCT06502834 Phase 1
Recruiting
Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)
Enrollment
20 pts
Country
🇳🇱 Netherlands
Max Nieuwdorp
View Trial → NCT05202353 Phase 1
Recruiting
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Enrollment
30 pts
Country
🇳🇱 Netherlands
Boehringer Ingelheim
View Trial → Frequently Asked Questions
How many obesity clinical trials are active in Netherlands?
There are currently 5 active clinical trials for obesity with sites in Netherlands, of which 5 are actively recruiting patients.
How can I join a obesity clinical trial in Netherlands?
To join a obesity clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are obesity trials in Netherlands?
Active obesity trials in Netherlands span Phase 4, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology